Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

NXGL Insider Trading

NEXGEL, INC. | Surgical & Medical Instruments & Apparatus

Comprehensive Trading Performance Summary

The investment history of corporate insiders at NEXGEL, INC. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Surgical & Medical Instruments & Apparatus sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2026-05-30 00:03 2026-05-27 Levy Adam R. Director, Officer - Chief Executive Officer SELL $0.60 13,000 $7,834 344,692 -3.6%
2025-12-29 16:47 2025-12-22 Levy Adam R. Director, Officer - Chief Executive Officer SELL $1.59 10,000 $15,947 357,692 -2.7%
2025-11-08 04:00 2025-11-06 Levy Adam R. Director, Officer - Chief Executive Officer SELL $2.52 4,000 $10,084 367,692 -1.1%
2025-10-07 03:00 2025-10-02 Henry Scott Robert Director SELL $2.55 8,000 $20,360 113,356 -6.6%
2025-10-07 03:00 2025-10-02 Levy Adam R. Director, Officer - Chief Executive Officer SELL $2.53 4,000 $10,119 371,692 -1.1%
2025-09-30 03:00 2025-09-25 Henry Scott Robert Director SELL $2.36 7,697 $18,149 121,356 -6.0%
2025-08-30 03:00 2025-08-28 Levy Adam R. Director, Officer - Chief Executive Officer SELL $2.47 4,000 $9,896 358,284 -1.1%
2025-06-17 03:00 2025-06-13 Henry Scott Robert Director SELL $2.57 3,000 $7,704 129,053 -2.3%
2025-06-12 03:00 2025-06-09 Levy Adam R. Director, Officer - Chief Executive Officer SELL $2.36 4,000 $9,439 362,284 -1.1%
2025-06-07 03:00 2025-06-04 Levy Adam R. Director, Officer - Chief Executive Officer SELL $2.31 2,000 $4,613 366,284 -0.5%
2025-06-03 03:00 2025-05-30 Levy Adam R. Director, Officer - Chief Executive Officer SELL $2.22 1,000 $2,220 368,284 -0.3%
2025-05-21 03:00 2025-05-16 Levy Adam R. Director, Officer - Chief Executive Officer SELL $2.58 1,000 $2,575 369,284 -0.3%
2025-05-14 03:00 2025-05-12 Henry Scott Robert Director SELL $2.69 3,000 $8,062 132,053 -2.2%
2025-04-15 00:00 2025-04-10 Henry Scott Robert Director SELL $2.61 3,000 $7,825 135,053 -2.2%
2025-04-03 00:00 2025-04-01 Levy Adam R. Director, Officer - Chief Executive Officer SELL $3.01 4,000 $12,038 370,284 -1.1%
2025-03-12 00:00 2025-03-10 Henry Scott Robert Director SELL $2.87 3,000 $8,621 138,053 -2.1%
2025-03-06 01:00 2025-03-03 Levy Adam R. Director, Officer - Chief Executive Officer SELL $3.16 4,000 $12,639 374,284 -1.1%
2025-02-13 01:00 2025-02-10 Henry Scott Robert Director SELL $3.27 3,000 $9,798 138,553 -2.1%
2025-02-06 01:00 2025-02-03 Levy Adam R. Director, Officer - Chief Executive Officer SELL $3.64 4,000 $14,558 378,284 -1.0%
2025-01-09 00:30 2025-01-07 Henry Scott Robert Director SELL $3.37 3,000 $10,097 141,553 -2.1%
2025-01-07 00:37 2025-01-02 Levy Adam R. Director, Officer - Chief Executive Officer SELL $3.96 4,000 $15,828 382,284 -1.0%
2024-12-24 01:00 2024-12-20 Henry Scott Robert Director SELL $4.64 3,000 $13,935 144,553 -2.0%
2024-11-23 00:54 2024-11-20 glassman steven mark Director BUY $2.75 9,090 $24,998 154,155 +6.3%
2024-11-23 00:54 2024-11-20 Henry Scott Robert Director BUY $2.75 1,818 $5,000 147,553 +1.2%
2024-11-23 00:54 2024-11-20 Levy Adam R. Director, Officer - Chief Executive Officer BUY $2.75 3,636 $9,999 333,196 +1.1%
2024-11-23 00:54 2024-11-20 Drapczuk Adam E III Officer - Chief Financial Officer BUY $2.75 17,500 $48,125 74,894 +30.5%
2024-11-23 00:54 2024-11-20 ZELDIS JEROME B Director BUY $2.75 3,636 $9,999 106,664 +3.5%
2024-11-23 00:54 2024-11-20 Stein John Nachum Director BUY $2.75 3,636 $9,999 471,456 +0.8%
2024-08-29 00:00 2024-08-23 Stein John Nachum Director BUY $2.50 10,000 $25,000 471,820 +2.2%
2024-08-28 04:14 2024-08-23 glassman steven mark Director BUY $2.50 10,000 $25,000 145,025 +7.4%
2024-08-28 04:11 2024-08-23 Henry Scott Robert Director BUY $2.50 10,000 $25,000 145,735 +7.4%
2024-08-28 04:09 2024-08-23 Drapczuk Adam E III Officer - Chief Financial Officer BUY $2.50 10,000 $25,000 57,394 +21.1%
2024-08-28 04:13 2024-08-23 ZELDIS JEROME B Director BUY $2.50 10,000 $25,000 103,028 +10.7%
2024-03-05 17:07 2024-03-01 Henry Scott Robert Director BUY $2.11 23,697 $50,001 135,735 +21.2%
2024-03-05 17:05 2024-03-01 glassman steven mark Director BUY $2.11 11,848 $24,999 135,025 +9.6%
2024-03-05 17:04 2024-03-01 Drapczuk Adam E III Officer - Chief Financial Officer BUY $2.11 47,394 $100,001 47,394 +100.0%
2023-12-27 00:15 2023-12-22 glassman steven mark Director BUY $2.20 3,885 $8,535 123,177 +3.3%
2023-09-29 00:28 2023-09-26 Stein John Nachum Director BUY $1.96 2,500 $4,900 500,019 +0.5%
2023-09-15 01:51 2023-09-12 Henry Scott Robert Director BUY $2.26 10,500 $23,750 112,038 +10.3%
2023-08-24 01:06 2023-08-21 Henry Scott Robert Director BUY $1.94 2,980 $5,781 101,538 +3.0%
2023-06-12 15:30 2023-06-08 Henry Scott Robert Director BUY $2.24 3,558 $7,984 98,558 +3.7%
2023-06-09 15:30 2023-06-07 STEFANSKY DAVID Director BUY $2.41 3,000 $7,220 50,091 +6.4%
2023-06-09 15:30 2023-06-07 Stein John Nachum Director BUY $2.49 10,000 $24,850 497,458 +2.1%
2023-06-03 02:20 2023-05-31 Henry Scott Robert Director BUY $2.35 3,000 $7,050 95,000 +3.3%
2023-06-01 15:30 2023-05-30 glassman steven mark Director BUY $2.38 4,200 $9,996 119,292 +3.6%
2023-06-01 15:30 2023-05-30 STEFANSKY DAVID Director BUY $2.50 7,000 $17,490 47,091 +17.5%
2023-05-30 23:05 2023-05-26 ZELDIS JEROME B Director BUY $2.34 5,000 $11,689 93,028 +5.7%
2023-05-25 00:40 2023-05-22 Henry Scott Robert Director BUY $1.96 7,000 $13,720 92,000 +8.2%
2022-12-20 00:25 2022-12-19 STEFANSKY DAVID Director BUY $1.59 5,000 $7,950 40,091 +14.2%
2022-12-14 00:11 2022-12-12 STEFANSKY DAVID Director BUY $1.44 7,500 $10,825 35,091 +27.2%
SHOW ENTRIES

How to Interpret $NXGL Trades

Not every insider transaction in NEXGEL, INC. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $NXGL shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for NXGL

Insider activity data for NEXGEL, INC. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $NXGL, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.